Sabbin Sabuntawa Akan Ingantacciyar Magance Against Cancer Cells

A KYAUTA Kyauta 1 | eTurboNews | eTN
Avatar na Linda Hohnholz
Written by Linda Hohnholz

Hoth Therapeutics, Inc. a yau ta sanar da sabuntawar haɓakawa don sabon maganin cutar kansa, HT-KIT. Sabuwar hanyar Hoth, wacce ke amfani da sinadari-tsayayyen antisense oligonucleotide don niyya KIT na proto-oncogene ta hanyar tsara kwafin KIT mRNA, yana da yuwuwar warkewar KIT da aka yi niyya ita kaɗai, ko a hade tare da wakilai waɗanda ke niyya da siginar KIT, a cikin jiyya. Malignancies masu alaƙa da KIT.

Ta hanyar yarjejeniyar bincike na kimiyya da aka ba da tallafi tare da Jami'ar Jihar North Carolina, ƙungiyar ta yi amfani da tsarin canza tsarin HT-KIT mRNA akan ƙwayoyin cutar sankarar bargo na mast cell a cikin vitro kuma sun gano cewa furotin KIT, sigina da aiki sun ragu. Jiyya tare da HT-KIT ya hana ci gaban kwayar cutar kansa da haifar da mutuwar tantanin halitta sama da awanni 72. A cikin samfurin linzamin kwamfuta na mast cell leukemia, haɓakar ƙari da shigar da wasu gabobin sun ragu kuma mutuwar ƙwayar ƙwayar cuta ta ƙaru lokacin da HT-KIT ta haifar da frameshifted c-KIT mRNA.

Hoth ya shigar da aikace-aikacen haƙƙin mallaka da yawa don kare wannan IP a duk faɗin duniya. 

"Tare da maganin mu na HT-KIT, muna jujjuya siginar cutar kansa mai mahimmanci wanda ke da hannu a cikin cututtukan daji masu yawa, irin su mastocytosis na jiki, cutar sankarar jini ta mast cell, ciwace-ciwacen hanji da kuma cutar sankarar myeloid mai tsanani. Hanyarmu tana guje wa tarzoma masu alaƙa da maye gurbin KIT ta hanyar niyya mRNA. Zagayen karatun mu na gaba yana gudana kuma muna farin cikin yin amfani da sakamakon taron Pre-IND da muka shirya da FDA daga baya a wannan shekara, "in ji Robb Knie, Babban Jami'in Hoth.

HT-KIT, sabon tsarin kwayoyin halitta, an sanya shi a matsayin Magungunan Marayu don maganin mastocytosis a farkon 2022. HT-KIT Hoth ya sami nasarar samar da yuwuwar samar da maganin HT-KIT tare da haɗin gwiwar WuXi STA.

FDA Orphan Drug Design an ba da ita ga magungunan bincike da ke magance cututtukan likita da ba kasafai ba ko yanayin da ke shafar ƙasa da mutane 200,000 a Amurka. Matsayin magungunan marayu yana ba da fa'idodi ga masu haɓaka magunguna, gami da taimako a cikin tsarin haɓaka ƙwayar cuta, ƙididdige ƙimar haraji don farashin asibiti, keɓancewa daga wasu kuɗaɗen FDA da shekaru bakwai na keɓancewar tallace-tallace bayan amincewa.

Game da marubucin

Avatar na Linda Hohnholz

Linda Hohnholz

Edita a shugaba don eTurboNews bisa ga eTN HQ.

Labarai
Sanarwa na
bako
0 comments
Bayanin Cikin Lissafi
Duba duk maganganu
0
Za a son tunanin ku, don Allah sharhi.x
()
x
Share zuwa...